Sign In
Buy LLY
$1,185.71
-7.09 (-0.594%)
At Close: Aug 07, 2026
What's Next For Eli Lilly Stock After A Solid Q2?
08:00am, Tuesday, 13'th Aug 2024
Eli Lilly stock (NYSE: LLY) recently reported its Q2 results, with revenues and earnings exceeding the street expectations. The pharmaceutical giant reported sales of $11.3 billion and adjusted earnin
Lilly opens state-of-the-art research and development center in the Boston Seaport
08:00am, Tuesday, 13'th Aug 2024
Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs New 346,000 square foot facility will accommoda
This 1 Piece of Good News for Eli Lilly Is Bad News for Hims & Hers Health Stock
07:05am, Tuesday, 13'th Aug 2024
Eli Lilly claims that it's finally producing enough of its weight loss drugs. Companies producing substitutes for those drugs may have trouble growing soon.
Why Eli Lilly Stock's Big Jump Last Week Could Be Just the Beginning of Another Huge Run
05:50am, Tuesday, 13'th Aug 2024
Lilly's Mounjaro and Zepbound are only warming up. The company has several other promising drugs in its lineup and pipeline.
Should Investors Buy Eli Lilly's (LLY) Stock After Strong Q2 Results?
07:05pm, Monday, 12'th Aug 2024
As one of the largest pharmaceutical companies, Eli Lilly (LLY) said its growth trajectory accelerated during Q2 as its medicines are reaching more people worldwide.
Eli Lilly Stock Finishes Lower After News of Bond Sale to Fund Morphic Deal
06:01pm, Monday, 12'th Aug 2024
Eli Lilly (LLY) shares finished Monday lower after a back-and-forth session in which an analyst upgrade sent them higher before news of $5 billion in bond sales pulled them into the red.
Eli Lilly is a 'great destination for investors', says Deutsche Bank's James Shin after upgrade
05:51pm, Monday, 12'th Aug 2024
James Shin, Deutsche Bank analyst, joins 'Closing Bell Overtime' to talk its big Eli Lilly upgrade.
Biotech stocks: Which drugmakers are worth a buy?
05:13pm, Monday, 12'th Aug 2024
While the pharma space has seen growing excitement over weight-loss drugs from Eli Lilly (LLY) and Novo Nordisk's (NVO) latest earnings, investors are increasingly curious over the types of innovation
3-Stock Lunch: Starbucks, Eli Lilly and JetBlue
04:23pm, Monday, 12'th Aug 2024
Scott Nations, Nations Indexes president, joins 'Power Lunch' to discuss stock plays for three stocks.
Eli Lilly (LLY), A.I. and State of the Mag 7
04:22pm, Monday, 12'th Aug 2024
Sylvia Jablonski with Defiance ETFs says she doesn't think "the macro market has changed," even after last week's turbulent market action. She joins Oliver Renick to share why Eli Lilly (LLY) "continu
Funds Load Up On Costco, Eli Lilly, These Other Stocks
02:58pm, Monday, 12'th Aug 2024
Fund managers have been busy buying amid the ongoing market weakness. Four stocks are near buy points or are building bases.
Eli Lilly price target raised by $300 to $1,025 by Deutsche Bank
01:40pm, Monday, 12'th Aug 2024
Deutsche Bank is out with a bullish call on Eli Lilly (LLY), raising its rating on the pharma stock from Hold to Buy and lifting its price target by $300 to a total of $1,025 a share. Deutsche Bank An
5 ETFs to Make the Most of Eli Lilly's Strength
12:52pm, Monday, 12'th Aug 2024
Impressed by Eli Lilly's (LLY) blowout earnings, several analysts raised their target price on the stock.
Eli Lilly Q2 Earnings: Thanks To Tirzepatide, $1 Trillion Valuation Now In Sight
12:18pm, Monday, 12'th Aug 2024
Eli Lilly and Company reported strong Q2 2024 earnings with revenues up 36% year-on-year, exceeding expectations. Guidance for 2024 was raised by ~$3bn with expectations of $45.4bn — $46.6bn in reve
International Markets and Lilly (LLY): A Deep Dive for Investors
10:21am, Monday, 12'th Aug 2024
Review Lilly's (LLY) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
